BRAF and metastatic melanoma: Our results show a significant reduction in cell viability 5 days after transfection of the metastatic melanoma cell lines WM266-4, A2058, 1205Lu (all BRAF V600-mutant) and SK-MEL-2 (BRAF WT, NRASQ61K) with miR-7-5p (Figure 1A).